Beaumont Health

Beaumont Health Scholarly Works and Archives
Articles

Physical Medicine and Rehabilitation

4-2022

What Is Meaningful Participation for Physical Therapists in
Multidisciplinary Cancer Conferences and Tumor Boards?
Stacy Weber
Athena A. Manzino
Christopher M. Wilson
Nicole D. Booms

Follow this and additional works at: https://scholarlyworks.beaumont.org/
physical_medicine_rehabilitation_articles
Part of the Physical Therapy Commons

C L I N I C A L

C O N V E R S A T I O N

What Is Meaningful Participation
for Physical Therapists in
Multidisciplinary Cancer
Conferences and Tumor Boards?
Stacy M. Weber, PT, DPT1 ; Athena A. Manzino, PT, DPT1 ; Christopher M. Wilson, PT, DPT, DScPT2 ;
Nicole D. Booms, PT, DPT, OMPT3
1

Oncology Physical Therapy Resident, Beaumont Health, Southfield, MI; 2 Board Certified Geriatric Clinical Specialist;
Associate Professor, Oakland University, Rochester, MI; and Founding Oncology Residency Director, Beaumont Hospital,
Troy, MI; and 3 Residency Program Director, Beaumont Hospital, Troy, MI

Tumor boards are multidisciplinary team meetings
composed of providers from different specialties who collaborate to provide comprehensive cancer care. Although
the term “tumor board” may be used commonly in practice,
these meetings are often referred to as multidisciplinary
cancer conferences (MCCs) within the literature and are
referred to as such in this article. At this time, there is
no current literature describing the role of physical therapists (PTs) and rehabilitation professionals as part of the
MCC or multidisciplinary tumor boards. Yet, PTs are often
included as part of this multidisciplinary team in cancer
care. This inclusion has not completely shifted to be the
standard of practice, although PTs have a unique understanding of the human movement system in the presence
and absence of disease, which is needed to intervene with
functional limitations, and improve the patient’s independence and quality of life (QOL). The purpose of this article
is to define MCCs, the benefits and barriers to participation as PTs, and possible next steps for rehabilitation
professionals.
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MULTIDISCIPLINARY CANCER CONFERENCES AND
TUMOR BOARDS
The purpose of MCCs is to develop a comprehensive cancer treatment plan for people with cancer and is
typically used for more challenging and complex cases.1
Various disciplines, including, but not limited to, medical oncologists, radiation oncologists, surgical oncologists,
radiologists, pathologists, social workers, and PTs, participate in coordinating comprehensive care.2 Participating
members in an MCC will vary by the type of cancer that is
being discussed. For example, a speech-language pathologist may be present at a head and neck MCC while gynecologists may regularly attend an MCC focusing on pelvic
and abdominal cancers. MCCs are typically held weekly or
biweekly and consist of a patient case review with discussion of patient management, diagnostics, and treatment.3
The American College of Surgeons’ Commission on Cancer
(CoC) supports the use of MCCs as an essential component
of cancer care in encompassing the full scope of providable
services.4
Although the CoC recommends that rehabilitation
providers be in attendance during the MCC, another organization, Cancer Care Ontario, strongly recommends PT
attendance and participation in MCCs.4,5 Despite these
recommendations, PTs have not been widely integrated
within MCCs; this may be due to limited awareness of the
PTs’ role in MCCs and limited preparation for meaningful
participation by PTs.5 PT integration within MCCs may
also be limited because of the variability in structure and
organization of MCCs, which may contribute to irregular
multidisciplinary participation.6
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THE PHYSICAL THERAPISTS’ ROLE IN
MULTIDISCIPLINARY CANCER CONFERENCES
To date, there have not been any studies to describe
or define the role of the PT within MCCs. PTs possess
specialized knowledge, training, and education to assess
impairments related to cancer pathology and treatment
side effects. Specifically, PTs are skilled in identifying and
treating impaired range of motion, weakness, fatigue, and
balance disorders, which can be resultant side effects from
chemotherapy, radiation therapy, and surgical treatment.7
An indication for further evaluation by PTs may include
patient or provider report of difficulty with physical performance or barriers to safe exercise performance.
In some MCCs, the patient and family are invited to
attend or hear summative recommendations. During this
visit, the PT may have the opportunity for direct interaction with the patient to provide screening, education, and
referral to additional services, when indicated. Screenings
may be highly variable based on the patient’s cancer but
may include common domains such as balance, gait speed,
and fatigue. These baseline data can be used for early identification of emerging issues or to demonstrate a return to
baseline after rehabilitation. Patients can also be educated
on when symptoms may require further intervention and
possible treatment by the care team (eg, lower-body weakness that does not resolve after cancer treatment is completed). In addition, it is within the PT’s scope of practice
to educate patients on referrals to other specialties and disciplines, depending on cancer diagnosis and possible side
effects of treatment. Options for referral include abdominal and pelvic floor physical therapy for genitourinary and
colorectal cancers, as well as speech-language pathology
for head and neck cancers.
As PTs are exercise specialists, especially with those
with physical, functional, or medical issues, they are well
positioned to facilitate the performance of physical activity during cancer treatment. The American College of
Sports Medicine (ACSM) Guidelines for Exercise and Cancer elaborate on the importance of physical activity and
exercise as a risk-reduction option for cancer and recurrence, symptom reduction during treatment, and a mechanism for increasing cancer survival.8 However, exercise
as an essential adjuvant to cancer treatment remains in the
early stages of acceptance and formation.9 The inclusion
of PTs in MCCs is one step toward preventing the omission of exercise as a critical part of the cancer treatment
plan.

early, many of the functional limitations that patients
develop as a result of cancer and its treatments can be
addressed.11
In 2018, the inaugural International Conference on
Physiotherapy in Oncology brought forth themes for
greater implementation and further advancement of oncology physical therapy. A notable theme was the decreased
awareness of physical therapy services for patients within
oncology care that results in a lower number of referrals to
physical therapy.11 An actionable step to remedy this disparity is to encourage PTs’ regular participation in MCCs.
The benefits of this are multifold in that other providers
of the multidisciplinary team will be exposed to the role
and benefits of physical therapy, allowing the opportunity
for advocacy for the profession and increasing conversations about the patient’s functional status and QOL. This
also further highlights the PT’s role in oncology care and
emphasizes movement and physical activity as an essential
component of comprehensive cancer care.
BARRIERS
It is important to be mindful of the potential barriers that exist within PTs’ participation in MCCs. First,
appropriately staffing and scheduling PTs to attend and
participate in MCCs can be challenging, as the conferences often occur prior to the typical workday, resulting
in a dilemma to participate in these events without compensation or MCCs occurring during direct patient care
hours and the logistical and financial implications thereof.
Critical issues may include salary cost considerations for
nonbillable PT time and logistical and financial implications of MCC involvement during patient care hours. A
recent survey by the APTA found that approximately 15%
of PT time is spent providing unbillable or uncompensated
care services (eg, MCCs) and 79% of respondents said that
barriers to providing these services negatively impacted
patient care.12
The authors are aware of several anecdotal reports
where PTs have attended MCCs for years and had never
said a word. This puts into question whether the PT’s skills
and knowledge are being fully leveraged. Although often
unfounded, some PTs may not feel comfortable bringing
up key issues even if they are material to the patient’s treatment plan or QOL. The limited research in MCCs indicates
the opposite may be true. In a qualitative study, Look Hong
et al found that MCC “participants were more likely to attend and participate in MCCs if there was a diversity of
clinical specialists and patient case topics.”6(p65)

POTENTIAL BENEFITS TO PT INTEGRATION
In alignment with the prospective surveillance
model and prevention-focused evaluation of physical
rehabilitation needs, early involvement by PTs can reduce
additional sequelae of impairments related to cancer
pathology and treatment.10 A PT’s involvement in the
MCC can increase the number of people with cancer
who are screened for rehabilitation needs. If identified
Rehabilitation Oncology, Vol. 40, No. 2

CALL TO ACTION
As movement specialists, PTs must advocate to be an
active and vital member of the oncology treatment team.
Active multidisciplinary engagement from PTs promotes
awareness among health care providers and educates patients about additional services to enhance meaningful
participation in everyday life. As it relates to research, a
PT Participation in Multidisciplinary Cancer Conferences
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multisite qualitative analysis of PTs who have participated
in MCCs and the perceptions of all involved would be a
beneficial starting point for this needed scholarly line of
inquiry and may lead to establishment of best practices for
PT involvement in this team.
SUMMARY
PTs’ participation in MCCs has not been widely studied and is likely underutilized despite the substantial evidence to support physical activity in cancer prevention, improving survival rates and QOL, and reducing negative side
effects of treatment such as fatigue, pain, balance disorders,
strength deficits, lymphedema, and functional limitations.
With a PT present in these conferences, there is potential
for advocacy for the profession to improve awareness of
PT skills among patients and interdisciplinary team members, thereby improving patient access to these services.
Therefore, it is essential for PTs to participate in MCCs to
screen for physical limitations and provide patient education with the overall goal of increasing appropriate access
and utilization of physical therapy services.
REFERENCES
1. Fox Chase Cancer Center. The important role tumor boards
play in cancer care. https://www.foxchase.org/blog/important-roletumor-boards-play-cancer-care. Published July 26, 2018. Accessed
November 28, 2021.
2. August C, Speights VO. What is a tumor board? Expert Q&A. https:
//www.cancer.net/blog/2017-07/what-tumor-board-expert-qa. Published July 12, 2017. Accessed November 28, 2021.

E38

Weber et al

3. El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving
efficiency of multidisciplinary management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book. 2014:e461-e466.
doi:10.14694/EdBook_AM.2014.34.e461.
4. Commission on Cancer. Optimal Resources for Cancer Care 2020 Standards. Chicago, IL: American College of Surgeons; 2021:3-4.
5. Cancer Care Ontario. Multidisciplinary cancer conferences. https://
www.cancercareontario.ca/en/guidelines-advice/cancer-continuum/
treatment/multidisciplinary-cancer-conferences?redirect=true.
Accessed November 28, 2021.
6. Look Hong NJ, Gagliardi AR, Bronskill SE, Paszat LF, Wright FC.
Multidisciplinary cancer conferences: exploring obstacles and facilitators to their implementation. J Oncol Pract. 2010;6(2):61-68.
doi:10.1200/JOP.091085.
7. Stefani L, Galanti G, Klika R. Clinical implementation of exercise guidelines for cancer patients: adaptation of ACSM’s guidelines to the Italian model. J Funct Morphol Kinesiol. 2017;2(4):1-15.
doi:10.3390/jfmk2010004.
8. American College of Sports Medicine. ACSM guidelines for exercise
and cancer. https://www.acsm.org/blog-detail/acsm-certified-blog/
2019/11/25/acsm-guidelines-exercise-cancer-download. Updated
November 25, 2019. Accessed November 16, 2021.
9. Wolin KY, Schwartz AL, Matthews CE, Courneya KS, Schmitz
KH. Implementing the exercise guidelines for cancer survivors. J
Support Oncol. 2012;10(5):171-177. doi:10.1016/j.suponc.2012.02.
001.
10. Stout NL, Binkley JM, Schmitz KH, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer.
2012;118(8)(suppl):2191-2200. doi:10.1002/cncr.27476.
11. Stuiver MM, Stout NL, Dennett AM, Speksnijder CM, Campbell KL.
An international perspective on integrating physiotherapists in oncology care. J Physiother. 2019;65(4):186-188.
12. Bell A. Uncompensated care: an ongoing problem. https://www.apta.
org/apta-magazine/2021/10/01/uncompensated-care. Published October 1, 2021. Accessed November 28, 2021.

Rehabilitation Oncology, Vol. 40, No. 2

Copyright © 2022 Academy of Oncologic Physical Therapy, APTA. Unauthorized reproduction of this article is prohibited.

